Read more about AI-powered peptide discovery could transform fight against drug-resistant superbugs on Devdiscourse ...

Intramolecular charge transfer (ICT) is one of the most important photophysical mechanisms in organic fluorophores. Among ICT processes, TICT ...

Researchers engineered the first RNA-based NAND gate in living cells using deep learning and Bayesian optimization, testing ...

Researchers from Edith Cowan University (ECU) are developing new technology that could change how drunk and dangerous drivers ...

An interdisciplinary research team from two working groups at the Center for Synthetic Biology at TU Darmstadt has developed the first RNA-based genetic switch that precisely replicates the logical ...

Tenaya leverages “human induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) with high-throughput in vitro screening, imaging analysis, and machine learning algorithms” to identify new ...

Immunis, Inc., a clinical-stage biotech company targeting age-related diseases, today announced it has entered an exclusive licensing agreement with Toray to develop and commercialize a drug candidate ...

Discover how AI startups are driving rapid AI industry disruption across healthcare, finance, marketing, and more—redefining innovation, efficiency, and the future of global industries.

Researchers developed a blood test that analyzes structural changes in three proteins linked to Alzheimer’s progression. Protein folding patterns distinguished healthy individuals, mild cognitive ...

Recent media coverage highlights the wide range of research, education, and scientific perspectives emerging from the SETI ...

Artificial intelligence is rapidly inventing new drugs for diseases from Parkinson's disease and antibiotic-resistant superbugs to rare lung conditions.

Systematic human inspection of the millions of source cutouts in the Hubble Legacy Archive is impossible – but artificial ...